MEDIPOST Co., Ltd. (KOSDAQ:078160)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,900.00
+340.00 (3.97%)
May 13, 2025, 3:30 PM KST
22.93%
Market Cap 303.48B
Revenue (ttm) 70.66B
Net Income (ttm) -62.52B
Shares Out 34.10M
EPS (ttm) -1,834.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 51,453
Average Volume 39,264
Open 8,770.00
Previous Close 8,560.00
Day's Range 8,630.00 - 9,090.00
52-Week Range 5,450.00 - 15,180.00
Beta 0.33
RSI 53.36
Earnings Date May 14, 2025

About MEDIPOST

MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia. Further, the co... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 308
Stock Exchange KOSDAQ
Ticker Symbol 078160
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.